CIDARA THERAPEUTICS INC (CDTX) Stock Balance Sheet
USA - NASDAQ:CDTX - US1717572069 - Common Stock
219.55 USD
+0.53 (+0.24%)
219.55 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 510.57M | 189.82M | 35.78M | 32.73M | 59.68M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 1.86M | 1.69M | 16.25M | 5.83M | 5.36M | |||
| Inventories | null | null | 6.10M | 0 | null | |||
| Other Current Assets | 19.36M | 19.22M | 2.73M | 6.53M | 6.66M | |||
| Total Current Assets | 531.79M | 210.74M | 60.85M | 45.09M | 71.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.44M | 3.96M | 5.13M | 1.32M | 2.54M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 95.00K | 96.00K | 1.05M | 1.07M | 1.08M | |||
| Total Non-Current Assets | 2.54M | 4.06M | 6.17M | 2.39M | 3.63M | |||
| TOTAL ASSETS | 534.33M | 214.80M | 67.03M | 47.49M | 75.33M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 0 | 264.00K | 218.00K | 0 | 2.59M | |||
| Accrued Expenses | 30.11M | 45.68M | 38.33M | 25.34M | 16.20M | |||
| Accounts Payable | 2.21M | 3.61M | 3.77M | 1.45M | 1.30M | |||
| Other Current Liabilities | null | 0 | 25.09M | 14.61M | 13.92M | |||
| Total Current Liabilities | 32.32M | 49.55M | 67.42M | 41.40M | 34.02M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 310.00K | 575.00K | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 836.00K | 1.62M | 7.25M | 20.52M | 19.73M | |||
| Total Non-Current Liabilities | 836.00K | 1.93M | 7.82M | 20.52M | 19.73M | |||
| TOTAL LIABILITIES | 33.15M | 51.49M | 75.24M | 61.92M | 53.75M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -660.46M | -611.26M | -441.43M | -418.50M | -377.17M | |||
| Additional Paid In Capital | 1.16B | 774.57M | 433.21M | 404.06M | 398.73M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 2.00K | 1.00K | 9.00K | 7.00K | 7.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | null | null | null | null | null | |||
| Shares Outstanding | 23.23M | 10.95M | 4.53M | 3.62M | 3.39M | |||
| Tangible Book Value per Share | 21.5699 | 14.9186 | -1.8124 | -3.984 | 6.3581 | |||
| Total Shareholders' Equity | 501.17M | 163.31M | -8.21M | -14.44M | 21.57M | |||
| TOTAL LIABILITIES AND EQUITY | 534.33M | 214.80M | 67.03M | 47.49M | 75.33M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.00 | -0.07 | N/A | N/A | |||
| Current Ratio | 16.45 | 4.25 | 0.90 | 1.09 | 2.11 | |||
| Return On Assets (ROA) | -21.99% | -79.06% | -34.21% | -70.72% | -56.38% | |||
| Return On Equity (ROE) | -23.44% | -103.99% | N/A | N/A | -196.85% | |||
All data in USD , ROIC based on taxRate of 0.21